Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.
Aug 16, 2014
4.5 / 5 (4) | 0
Researchers have published a study examining racial and ethnic influences in the outcomes of patients with motor complete spinal cord injury (SCI). The article, "Racial and ethnic disparities in functioning at discharge and ...
10 hours ago
5 / 5 (1) | 0